E-PaperPharma Sector News
India to join global scheme to improve quality of drugs | Mint Primer | Mint
This video explores the reasons behind India's decision to join PIC/S and its potential impact on the Indian pharmaceutical market. The UAE and other advanced economies often reference prices in developed markets, which pose barriers for affordable Indian drugs, despite their superior quality. Talks are underway to address pricing norms and facilitate Indian generic drug and vaccine exports. The absence of India and China from PIC/S has skewed the price mechanism towards higher prices, hindering Indian exporters of affordable medicines
9 Jun 2023Indian Pharma Industry Poised for Growth in 2023 and Beyond | Mint Explains | Mint
Indian pharma in 2023: Industry experts give big thumbs up to the sector. Here's what they are saying. According to a recent EY FICCI report, the Indian pharmaceutical market is estimated to touch $130 billion in value by the end of 2030.
7 May 2023Specialty chemical firms pivot to pharma
Specialty chemical firms, which were eyeing the intermediates business for the past few years, received a boost from the pandemic and the focus on localizing pharmaceutical supply chains
2 min read8 Sep 2020Pharma sector mutual funds give 58% returns, top the charts in one year
DSP Healthcare Fund generated the highest returns of 69.80% in the last one yearNifty pharma index grew by 51.5% in last one year
1 min read16 Aug 2020As pharma valuations rise, volume slowdown becomes a concern
Indian pharma market growth slowed in April-May, due to lower number of drug prescriptions
2 min read14 Jun 2020Pharma: steady domestic demand lends support, valuations stay mixed
Sales in February rebounded, registering 12.1% growth year-on-year
2 min read22 Mar 2020India to conduct carcinogen test on ranitidine even as USFDA downplays risks
Earlier this month, the US FDA downplayed the risk associated with ranitidineThe safety alert triggered considerable chaos in the pharmaceutical sector worldwide
2 min read21 Nov 2019Mylan to invest $1 billion in India on capex in 6 years
Mylan global president Rajiv Malik said the firm had been investing close to about $400 mn or $450 mn towards capex every year and half of it in IndiaCurrently Maylan has 21 facilities and 15,000 employees working in India
2 min read29 Sep 2019Drug regulator preparing list of dual-use APIs imported from unregistered firms
India imports almost 80% of its API requirement from ChinaOnce the list of such APIs are prepared, it will be submitted to the Department of Pharmacueticals
1 min read25 Aug 2019Facing headwinds in US, Natco Pharma looks to scale up business in China
Natco Pharma is focusing on filing of the cancer treatment drugs in China as part of its strategy to diversify business in emerging markets amid headwinds in the USChina's pharma market is likely to grow at 3-6% to $140-170 bn by 2023 as against Brazil which is likely to grow at 5-8% to $30-43 bn
1 min read11 Aug 2019Popular Topics
Budget
The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared